TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T93266	Hyperpolarization cyclic nucleotide-gated channel 1	B4GO9S	2-Ethoxy-N-[[1-(4-phenylpiperazin-1-yl)cyclohexyl]methyl]benzamide	Investigative	56672421	C26H35N3O2	421.6	CCOC1=CC=CC=C1C(=O)NCC2(CCCCC2)N3CCN(CC3)C4=CC=CC=C4	IC50 ~ 199526.23 nM	Poor binder
T93266	Hyperpolarization cyclic nucleotide-gated channel 1	B4VJ8P	3-Methoxy-N-[[2-(4-methylpiperazin-1-yl)-1,3-dihydroinden-2-yl]methyl]benzamide	Investigative	56672532	C23H29N3O2	379.5	CN1CCN(CC1)C2(CC3=CC=CC=C3C2)CNC(=O)C4=CC(=CC=C4)OC	IC50 = 63095.73 nM	Poor binder
T93266	Hyperpolarization cyclic nucleotide-gated channel 1	B5DQ6U	4-Methoxy-N-[[2-(4-methylpiperazin-1-yl)-1,3-dihydroinden-2-yl]methyl]benzamide	Investigative	56679227	C23H29N3O2	379.5	CN1CCN(CC1)C2(CC3=CC=CC=C3C2)CNC(=O)C4=CC=C(C=C4)OC	IC50 = 100000 nM	Poor binder
T93266	Hyperpolarization cyclic nucleotide-gated channel 1	BBVU25	2-Ethyl-N-[[1-(4-propan-2-ylpiperazin-1-yl)cyclohexyl]methyl]benzamide	Investigative	56682419	C23H37N3O	371.6	CCC1=CC=CC=C1C(=O)NCC2(CCCCC2)N3CCN(CC3)C(C)C	IC50 ~ 199526.23 nM	Poor binder
T93266	Hyperpolarization cyclic nucleotide-gated channel 1	BBZ52A	2-Chloro-N-[[1-(4-methylpiperazin-1-yl)cyclohexyl]methyl]benzamide	Investigative	39734391	C19H28ClN3O	349.9	CN1CCN(CC1)C2(CCCCC2)CNC(=O)C3=CC=CC=C3Cl	IC50 ~ 199526.23 nM	Poor binder
T93266	Hyperpolarization cyclic nucleotide-gated channel 1	BDEY35	2-Hydroxy-N-[[2-(4-methylpiperazin-1-yl)-1,3-dihydroinden-2-yl]methyl]benzamide	Investigative	56675914	C22H27N3O2	365.5	CN1CCN(CC1)C2(CC3=CC=CC=C3C2)CNC(=O)C4=CC=CC=C4O	IC50 ~ 199526.23 nM	Poor binder
T93266	Hyperpolarization cyclic nucleotide-gated channel 1	BEVG30	2-Methoxy-N-[(2-piperidin-1-yl-1,3-dihydroinden-2-yl)methyl]benzamide	Investigative	56658685	C23H28N2O2	364.5	COC1=CC=CC=C1C(=O)NCC2(CC3=CC=CC=C3C2)N4CCCCC4	IC50 = 50118.72 nM	Poor binder
T93266	Hyperpolarization cyclic nucleotide-gated channel 1	BT3S2J	2-Methoxy-N-[2-(4-methylpiperazin-1-yl)ethyl]benzamide	Investigative	17616875	C15H23N3O2	277.36	CN1CCN(CC1)CCNC(=O)C2=CC=CC=C2OC	IC50 ~ 199526.23 nM	Poor binder
T93266	Hyperpolarization cyclic nucleotide-gated channel 1	BX3SJ8	2-Methyl-N-[[1-(4-methylpiperazin-1-yl)cyclohexyl]methyl]benzamide	Investigative	56665614	C20H31N3O	329.5	CC1=CC=CC=C1C(=O)NCC2(CCCCC2)N3CCN(CC3)C	IC50 = 63095.73 nM	Poor binder
T93266	Hyperpolarization cyclic nucleotide-gated channel 1	BZV4C5	2-Methoxy-N-[(1-morpholin-4-ylcyclohexyl)methyl]benzamide	Investigative	16015637	C19H28N2O3	332.4	COC1=CC=CC=C1C(=O)NCC2(CCCCC2)N3CCOCC3	IC50 ~ 199526.23 nM	Poor binder